  | Jansen, N., Deneufbourg, J.-M., & Nickers, P. (15 March 2007). Adjuvant stereotactic permanent seed breast implant: A boost series in view of partial breast irradiation. International Journal of Radiation, Oncology, Biology, Physics, 67 (4), 1052-1058. doi:10.1016/j.ijrobp.2006.10.031  Peer Reviewed verified by ORBi |
 | Jansen, N., & Nickers, P. (October 2006). A new technique of stereotactic permanent breast seed implantation. Radiotherapy and Oncology, 81 (Suppl. 1), 249-S250. Peer Reviewed verified by ORBi |
 | Nickers, P., Coppens, L., De Leval, J., Jansen, N., & Deneufbourg, J.-M. (June 2006). 192ir Low Dose Rate Brachytherapy for Boosting Locally Advanced Prostate Cancers after External Beam Radiotherapy: A Phase Ii Trial. Radiotherapy and Oncology, 79 (3), 329-34. doi:10.1016/j.radonc.2006.05.013 Peer Reviewed verified by ORBi |
  | Nickers, P., Albert, A., Waltregny, D., & Deneufbourg, J.-M. (01 May 2006). Prognostic value of PSA nadir < or =4 ng/ml within 4 months of high-dose radiotherapy for locally advanced prostate cancer. International Journal of Radiation, Oncology, Biology, Physics, 65 (1), 73-77. doi:10.1016/j.ijrobp.2005.11.026 Peer Reviewed verified by ORBi |
 | Jansen, N., Nickers, P., & Deneufbourg, J.-M. (February 2006). L'irradiation partielle du sein et le role de la curietherapie: une nouvelle approche therapeutique pour les carcinomes mammaires de bon pronostic. Revue Médicale de Liège, 61 (2), 97-103. Peer reviewed |
 | Nickers, P., Thissen, B., Jansen, N., & Deneufbourg, J.-M. (January 2006). 192-Ir or 125-I Prostate Brachytherapy as a Boost to External Beam Radiotherapy in Locally Advanced Prostatic Cancer: A Dosimetric Point of View. Radiotherapy and Oncology, 78 (1), 47-52. doi:10.1016/j.radonc.2005.09.002 Peer Reviewed verified by ORBi |
 | Nickers, P., Lenaerts, E., Thissen, B., & Deneufbourg, J.-M. (February 2005). Does inverse planning applied to Iridium192 high dose rate prostate brachytherapy improve the optimization of the dose afforded by the Paris system? Radiotherapy and Oncology, 74 (2), 131-136. doi:10.1016/j.radonc.2004.10.013 Peer Reviewed verified by ORBi |
 | Deneufbourg, J.-M., BARTHELEMY, N., & NICKERS, P. (2004). CHU de Liège Service de Radiothérapie - Oncologie. Liège, Belgium: Université de Liège CHU de Liège. |
 | Nickers, P., Thissen, B., Jansen, N., & Deneufbourg, J.-M. (October 2004). 192lr LDR brachytherapy(BT) is at least as efficient as HDR options for boosting unfavourable prostate cancers after EBRT. Proposals for future prospects. Radiotherapy and Oncology, 73 (Suppl. 1), 83. Peer Reviewed verified by ORBi |
 | Nickers, P., Jansen, N., Thissen, B., & Deneufbourg, J.-M. (May 2004). 192Ir LDR Brachytherapy(BT) is at least as efficient as HDR options for boosting intermediate or unfavourable prostate cancers after EBRT. Experience on 201 patients. Radiotherapy and Oncology, 71 (Suppl. 2), 124-S125. Peer Reviewed verified by ORBi |
 | Nickers, P., & Deneufbourg, J.-M. (August 2003). La curietherapie prostatique: realites et perspectives. Cancer Radiotherapie, 7 (4), 266-73. doi:10.1016/S1278-3218(03)00043-X Peer Reviewed verified by ORBi |
 | Belhocine, T., Thille, A., Fridman, V., Albert, A., Seidel, L., Nickers, P., Kridelka, F., & Rigo, P. (October 2002). Contribution of whole-body (18)FDG PET imaging in the management of cervical cancer. Gynecologic Oncology, 87 (1), 90-97. doi:10.1006/gyno.2002.6769 Peer Reviewed verified by ORBi |
 | Nickers, P., Coppens, L., Beauduin, M., Sabatier, J., Albert, A., de Leval, J., & Deneufbourg, J.-M. (2001). PSA kinetics after external beam radiotherapy alone or combined with an iridium brachytherapy boost to deliver 85 grays to prostatic adenocarcinoma. Strahlentherapie und Onkologie, 177 (2), 90-5. doi:10.1007/PL00002389 Peer Reviewed verified by ORBi |
 | Jansen, N., Nickers, P., & Devoghel, J.-C. (2000). La douleur pelvienne chez le patient oncologique. Oncologie, 2 (4), 187-200. Peer Reviewed verified by ORBi |
 | Nickers, P., Coppens, L., Beauduin, M., Darimont, M., de Leval, J., & Deneufbourg, J.-M. (2000). Feasibility study combining low dose rate (192)Ir brachytherapy and external beam radiotherapy aiming at delivering 80-85 Gy to prostatic adenocarcinoma. Radiotherapy and Oncology, 55 (1), 41-47. doi:10.1016/S0167-8140(00)00142-0 Peer Reviewed verified by ORBi |